| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
phenotype | 0.570 | None | 1.000 | 5 | 0 | 1999 | 2017 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
phenotype | 0.570 | None | 1.000 | 3 | 0 | 2001 | 2009 | ||||||||
|
C-X-C motif chemokine ligand 1 | 0.449 | 0.923 | 0.12 |
|
phenotype | 0.220 | None | 1.000 | 2 | 0 | 1996 | 2009 | ||||||||
|
peroxisome proliferator activated receptor gamma | 0.358 | 0.885 | 2.9E-02 |
|
phenotype | 0.520 | None | 1.000 | 2 | 0 | 2006 | 2011 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
phenotype | 0.600 | None | 1.000 | 2 | 0 | 2001 | 2016 | ||||||||
|
prostaglandin E receptor 4 | 0.558 | 0.731 | 0.98 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
phospholipase A2 group IVA | 0.496 | 0.846 | 6.0E-05 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2007 | 2015 | ||||||||
|
prostaglandin E synthase | 0.540 | 0.769 | 0.71 |
|
phenotype | 0.510 | None | 1.000 | 1 | 0 | 2003 | 2015 | ||||||||
|
proprotein convertase subtilisin/kexin type 2 | 0.663 | 0.462 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
proprotein convertase subtilisin/kexin type 1 | 0.548 | 0.615 | 2.7E-09 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
F11 receptor | 0.542 | 0.731 | 1.8E-05 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2006 | 2007 | ||||||||
|
opioid receptor mu 1 | 0.457 | 0.808 | 7.9E-11 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
neurotrophic receptor tyrosine kinase 2 | 0.479 | 0.808 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
neuropeptide Y receptor Y5 | 0.691 | 0.462 | 6.4E-03 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
nerve growth factor | 0.391 | 0.885 | 0.82 |
|
phenotype | 0.510 | None | 1.000 | 1 | 0 | 2000 | 2009 | ||||||||
|
bradykinin receptor B2 | 0.585 | 0.808 | 0.12 |
|
phenotype | 0.510 | None | 1.000 | 1 | 0 | 1995 | 2010 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
phenotype | 0.530 | None | 1.000 | 1 | 0 | 2003 | 2010 | ||||||||
|
phosphodiesterase 5A | 0.513 | 0.731 | 1.1E-04 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
neuropeptide FF-amide peptide precursor | 0.821 | 0.154 | 3.6E-05 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
calcium/calmodulin dependent protein kinase II alpha | 0.612 | 0.538 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
calcitonin related polypeptide alpha | 0.416 | 0.923 | 1.6E-02 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2001 | 2011 | ||||||||
|
transient receptor potential cation channel subfamily V member 1 | 0.446 | 0.885 | 1.0E-16 |
|
phenotype | 0.520 | None | 1.000 | 1 | 0 | 2007 | 2011 | ||||||||
|
toll like receptor 2 | 0.361 | 0.923 | 1.0E-06 |
|
phenotype | 0.560 | None | 1.000 | 1 | 0 | 2005 | 2012 |